From what 0 stock analysts predict, the share price for Hybrid Coating Technologies, Inc. (HCTI) might decrease by 100% in the next year. This is based on a 12-month average estimation for HCTI. Price targets go from $ to $. The majority of stock analysts believe HCTI is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
About 0 Wall Street analysts have assigned HCTI 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Hybrid Coating Technologies, Inc. to perform worse than the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on HCTI. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of HCTI.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Constantine Davides EF Hutton | Buy | $2 | Maintains | Sep 28, 2022 |
Constantine Davides EF Hutton | Buy | $4 | Initiates | Mar 14, 2022 |
When did it IPO
2021
Staff Count
22
Country
United States
Sector/Industry
Healthcare/Health Information Services
CEO
Mr. Anand Kumar
Market Cap
$1.8M
In 2023, HCTI generated $33.2M in revenue, which was a decrease of -27.64% from the previous year. This can be seen as a signal that HCTI's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
No news data available.